{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:20:59Z","timestamp":1788128459478,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jcin.2021.08.078","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T16:00:32Z","timestamp":1636992032000},"page":"2477-2486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent"],"prefix":"10.1016","volume":"14","author":[{"given":"Nicole D.","family":"van Hemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Voskuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Rozemeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e8ra","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Frambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia Z.","family":"Rittersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan O.","family":"Kraaijeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert E.H.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter R.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jcin.2021.08.078_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2021.08.078_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.08.078_bib3","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jcin.2021.08.078_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2021.08.078_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","article-title":"Drug-eluting coronary stents: insights from preclinical and pathology studies","volume":"17","author":"Torii","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2021.08.078_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (Real Safety and Efficacy\u00a0of 3-Month Dual Antiplatelet Therapy Following Endeavor Zotarolimus-Eluting Stent Implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib10","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2021.08.078_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ijcard.2014.08.031","article-title":"Randomized comparison between 3-month Cre8 DES vs. 1-month Vision\/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study","volume":"176","author":"Prati","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4244\/EIJV7I9A173","article-title":"Cre8\u2122 coronary stent: preclinical in\u00a0vivo assessment of a new generation polymer-free DES with Amphilimus\u2122 formulation","volume":"7","author":"Moretti","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2021.08.078_bib13","first-page":"410","article-title":"Rationale and design of Amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): a multicenter randomized clinical trial","volume":"91","author":"Rozemeijer","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2021.08.078_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.118.037707","article-title":"Randomized all-comers evaluation of a permanent polymer zotarolimus-eluting stent versus a polymer-free Amphilimus-eluting stent","volume":"139","author":"Rozemeijer","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2021.08.078_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/17434440.2020.1740587","article-title":"The Cre8 Amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile","volume":"17","author":"Pivato","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.jcin.2021.08.078_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2021.08.078_bib17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.4244\/EIJ-D-16-00571","article-title":"Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial","volume":"12","author":"Van Der Heijden","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2021.08.078_bib18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jcin.2019.04.054","article-title":"Thin, very thin, or ultrathin strut biodegradable or durable polymer-coated drug-eluting stents","volume":"12","author":"Buiten","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.08.078_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcin.2016.11.007","article-title":"Comparison of durable-polymer zotarolimus-eluting and biodegradable-polymer biolimus-eluting coronary stents in patients with coronary artery disease: 3-year clinical outcomes in the randomized SORT OUT VI trial","volume":"10","author":"Raungaard","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.08.078_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4244\/EIJ-D-19-00296","article-title":"Clinical outcomes of long stent in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry","volume":"16","author":"Kong","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2021.08.078_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2019.10.058","article-title":"Five-year clinical outcome of multicenter randomized trial comparing Amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions","volume":"301","author":"Carri\u00e9","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2021.08.078_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","article-title":"Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V trial","volume":"13","author":"Kandzari","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"27","key":"10.1016\/j.jcin.2021.08.078_bib23","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/eurheartj\/ehab280","article-title":"Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Madhavan","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2021.08.078_bib24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","article-title":"Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction","volume":"65","author":"Yeh","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jcin.2021.08.078_bib25","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.115.021158","article-title":"Individualizing duration of dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention","volume":"133","author":"Bagai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2021.08.078_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11936-012-0223-4","article-title":"Antiplatelet therapy after coronary stenting","volume":"15","author":"Galper","year":"2013","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jcin.2021.08.078_bib27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.clinthera.2016.02.016","article-title":"Dual antiplatelet therapy duration: a review of current\u00a0available evidence","volume":"38","author":"Mastoris","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcin.2021.08.078_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A\u00a0randomized comparison of reservoir-based polymer-free Amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus the RESERVOIR clinical trial","volume":"9","author":"Romaguera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.08.078_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.03.088","article-title":"One-year clinical outcome of Amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: insight from the ASTUTE registry (Amphilimus Italian Multicentre Registry)","volume":"214","author":"Colombo","year":"2016","journal-title":"Int J Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821017027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821017027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:15:07Z","timestamp":1761848107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879821017027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1936879821017027"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2021.08.078","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2021.08.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}